This new AI heart disease detector can’t be beat. S (SHD) refers to defects in the heart’s valves, wall or chambers that are present at birth or develop ...

With the help of artificial intelligence (AI), an inexpensive test found in many doctors' offices may soon be used to screen ...

With the help of artificial intelligence (AI), an inexpensive test found in many doctors' offices may soon be used to screen ...

Tempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) ...

Doctors have long called hypertrophic cardiomyopathy (HCM) “the great masquerader. ” It hides in plain sight, often mistaken ...

An artificial intelligence model developed by Mayo Clinic and Ultromics accurately screens for cardiac amyloidosis using a ...

This marks the second FDA-cleared ECG-AI device in Tempus’ cardiovascular product suite, following its previously cleared Tempus ECG-AF solution. The new software analyzes resting, non-ambulatory ...

Testing the Scanner According to the Independent, the AI scanner was tested on 26 heart-failure patients from five NHS trusts ...

Kevin Choi uses AI to detect critical diseases early through retinal scans. He said AI helps in screening, but it won't ...

In comparative analysis, EchoGo® Amyloidosis outperformed two validated clinical scoring systems, the Transthyretin Cardiac ...

A powerful new artificial intelligence system has shown it can predict who is at risk of sudden cardiac death far better than ...

An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in ...